EIF2AK3 and acute lymphoblastic leukemia: To further investigate the role of PERK in vivo, we generated mice that are conditionally PERK deficient in ECs (VE-cadherinERT2-Cre/PERKF/F) and assessed T-ALL development in these mice as well as the control PERKF/F mice (Fig. S4A).